(Q43974390)

28 November 2017

Ethanol, endocannabinoids, and the cannabinoidergic signaling system (English)

1 reference

28 November 2017

endocannabinoid system

0 references

0 references

9

George F Koob

1 reference

28 November 2017

Basalingappa L Hungund

1

1 reference

28 November 2017

Balapal S Basavarajappa

2

1 reference

28 November 2017

Csaba Vadasz

3

1 reference

28 November 2017

George Kunos

4

1 reference

28 November 2017

Fernando Rodriguez de Fonseca

5

1 reference

28 November 2017

Giancarlo Colombo

6

1 reference

28 November 2017

Salvatore Serra

7

1 reference

28 November 2017

Loren Parsons

8

1 reference

28 November 2017

1 April 2002

1 reference

Alcoholism: Clinical and Experimental Research

28 November 2017

1 reference

28 November 2017

26

1 reference

28 November 2017

565-574

1 reference

28 November 2017

4

1 reference

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

28 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Cannabinoid receptor agonist-stimulated [35S]guanosine triphosphate gammaS binding in the brain of C57BL/6 and DBA/2 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Sardinian alcohol-preferring rats: a genetic animal model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Cannabinoid receptor gene (CNR1): association with i.v. drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Effects of SR141716A on ethanol and sucrose self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Cannabinoid transmission and reward-related events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Search for endogenous ligands of the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

The endocannabinoid system as a target for therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

A second endogenous cannabinoid that modulates long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02575.X

10.1111/J.1530-0277.2002.TB02575.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference